Related Experiment Videos
Plasminogen activator inhibitor type 2 in human corneal epithelium
1Department of Dermatology, University of Pennsylvania School of Medicine, Philadelphia 19104-6142, USA.
Insights
Plasminogen activator inhibitor type 2 (PAI-2) is present in normal human corneal epithelium, both in vivo and in vitro. This protein is cell-associated and may play a role in corneal keratinocyte differentiation and death.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- The human corneal epithelium serves as a protective barrier.
- Understanding the molecular components of corneal epithelial cells is crucial for ocular health.
- Plasminogen activator inhibitor type 2 (PAI-2) is a serine protease inhibitor with known roles in inflammation and cell differentiation.
Purpose of the Study:
- To investigate the presence and state of plasminogen activator inhibitor type 2 (PAI-2) in normal human corneal epithelium.
- To determine if PAI-2 expression differs between in vivo and in vitro conditions.
Main Methods:
- Normal human corneas were utilized for both frozen sections and keratinocyte cultures.
- Immunohistochemistry and Western blot analysis were employed to detect PAI-2.
- Antibodies recognizing all forms of PAI-2 were used for comprehensive analysis.
Main Results:
- PAI-2 was localized to superficial corneal keratinocytes in both in vivo and in vitro settings.
- The relaxed (cleaved) conformation of PAI-2 was detected, with distinct patterns in vivo versus in vitro.
- Western blot confirmed that PAI-2 is predominantly cell-associated and functionally active within these cells.
Conclusions:
- This study provides the first evidence of PAI-2 in normal human corneal epithelium.
- PAI-2 is identified as a differentiation product of corneal keratinocytes.
- Cytoplasmic localization and cleavage of PAI-2 suggest a role in terminal differentiation and apoptosis of corneal epithelial cells.
Purpose:
To examine normal human corneal epithelium in vivo and in vitro for expression and status of plasniinogcn activ:ltor inhibitor type 2 (PAI-2).
Methods:
Normal hiuman corneas were prepared for frozen sections and for culture of corneal keratinocytes. PAI-2 was analyzed by immunohistochemistry and western blot analysis uising antibodies that recognize all forms of PAI-2.
Results:
In vivo and in vitro, PAI-2 was immunohistochemically localized to the superficial corneal keratinocytes. Immunostaining also revealed the presence of PAI-2 in its relaxed (i.e., cleaved) conformation. In vivo, the staining pattern of the relaxed form was identical with that of total PAI-2, but in vitro the relaxed form was detected in a smaller subpopulation of superficial cells. In vitro, the staining pattern indicated a cytoplasmic localization for PAI-2. Western blot analysis revealed that most of the PAI-2 was cell associated and functionally active.
Conclusions:
The present results are the first to show that PAI-2 is found in normal human corneal epithelium in vivo and in vitro, where it can be considered as a differentiation product. At least in vitro, all detectable PAI-2 is cell associated, with a cytoplasmic distribution. A subpopulation of keratinocytes also contains PAI-2 in its relaxed (i.e., cleaved) conformation. Cleavage by an as yet unidentified cytoplasmic proteinase may constitute a crucial aspect of the function of corneal epithelial PAI-2, which may be relevant to terminal differentiation and death of the corneal keratinocyte.